nodes	percent_of_prediction	percent_of_DWPC	metapath
Capecitabine—CYP2C9—Rosuvastatin—atherosclerosis	0.0867	0.267	CbGbCtD
Capecitabine—CYP2C9—Simvastatin—atherosclerosis	0.0806	0.248	CbGbCtD
Capecitabine—CYP2C9—Lovastatin—atherosclerosis	0.0789	0.243	CbGbCtD
Capecitabine—CYP2C9—Pravastatin—atherosclerosis	0.0789	0.243	CbGbCtD
Capecitabine—TYMP—endothelium—atherosclerosis	0.00769	0.125	CbGeAlD
Capecitabine—TYMP—blood vessel—atherosclerosis	0.00709	0.115	CbGeAlD
Capecitabine—DPYD—adipose tissue—atherosclerosis	0.00482	0.0783	CbGeAlD
Capecitabine—CDA—adipose tissue—atherosclerosis	0.00463	0.0753	CbGeAlD
Capecitabine—TYMP—connective tissue—atherosclerosis	0.00364	0.0591	CbGeAlD
Capecitabine—DPYD—liver—atherosclerosis	0.00338	0.0549	CbGeAlD
Capecitabine—CDA—liver—atherosclerosis	0.00325	0.0528	CbGeAlD
Capecitabine—TYMP—cardiovascular system—atherosclerosis	0.00316	0.0515	CbGeAlD
Capecitabine—CES1—connective tissue—atherosclerosis	0.00314	0.0511	CbGeAlD
Capecitabine—TYMS—connective tissue—atherosclerosis	0.00312	0.0507	CbGeAlD
Capecitabine—TYMP—adipose tissue—atherosclerosis	0.00279	0.0454	CbGeAlD
Capecitabine—CES1—cardiovascular system—atherosclerosis	0.00273	0.0444	CbGeAlD
Capecitabine—TYMS—Fluvastatin—Rosuvastatin—atherosclerosis	0.00264	0.268	CbGdCrCtD
Capecitabine—TYMS—Simvastatin—Lovastatin—atherosclerosis	0.00252	0.256	CbGdCrCtD
Capecitabine—TYMS—Simvastatin—Pravastatin—atherosclerosis	0.00252	0.256	CbGdCrCtD
Capecitabine—CES1—adipose tissue—atherosclerosis	0.00241	0.0392	CbGeAlD
Capecitabine—TYMS—adipose tissue—atherosclerosis	0.00239	0.0389	CbGeAlD
Capecitabine—TYMS—Pitavastatin—Rosuvastatin—atherosclerosis	0.00215	0.219	CbGdCrCtD
Capecitabine—TYMP—liver—atherosclerosis	0.00196	0.0318	CbGeAlD
Capecitabine—CES1—liver—atherosclerosis	0.00169	0.0275	CbGeAlD
Capecitabine—TYMS—liver—atherosclerosis	0.00168	0.0273	CbGeAlD
Capecitabine—CYP2C9—cardiovascular system—atherosclerosis	0.00119	0.0193	CbGeAlD
Capecitabine—CYP2C9—liver—atherosclerosis	0.000733	0.0119	CbGeAlD
Capecitabine—Erythema—Simvastatin—atherosclerosis	0.000597	0.00151	CcSEcCtD
Capecitabine—Ill-defined disorder—Lovastatin—atherosclerosis	0.000592	0.0015	CcSEcCtD
Capecitabine—Eye disorder—Niacin—atherosclerosis	0.000589	0.00149	CcSEcCtD
Capecitabine—Flatulence—Simvastatin—atherosclerosis	0.000588	0.00149	CcSEcCtD
Capecitabine—Tinnitus—Niacin—atherosclerosis	0.000587	0.00149	CcSEcCtD
Capecitabine—Erythema multiforme—Pravastatin—atherosclerosis	0.000586	0.00149	CcSEcCtD
Capecitabine—Dysgeusia—Simvastatin—atherosclerosis	0.000585	0.00148	CcSEcCtD
Capecitabine—Flushing—Niacin—atherosclerosis	0.000585	0.00148	CcSEcCtD
Capecitabine—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000581	0.00147	CcSEcCtD
Capecitabine—Anaemia—Ezetimibe—atherosclerosis	0.000579	0.00147	CcSEcCtD
Capecitabine—Tinnitus—Pravastatin—atherosclerosis	0.000578	0.00147	CcSEcCtD
Capecitabine—Malaise—Lovastatin—atherosclerosis	0.000576	0.00146	CcSEcCtD
Capecitabine—Cardiac disorder—Pravastatin—atherosclerosis	0.000576	0.00146	CcSEcCtD
Capecitabine—Flushing—Pravastatin—atherosclerosis	0.000576	0.00146	CcSEcCtD
Capecitabine—Muscle spasms—Simvastatin—atherosclerosis	0.000574	0.00145	CcSEcCtD
Capecitabine—Vertigo—Lovastatin—atherosclerosis	0.000574	0.00145	CcSEcCtD
Capecitabine—Angiopathy—Niacin—atherosclerosis	0.000571	0.00145	CcSEcCtD
Capecitabine—Leukopenia—Lovastatin—atherosclerosis	0.000571	0.00145	CcSEcCtD
Capecitabine—Chills—Niacin—atherosclerosis	0.000565	0.00143	CcSEcCtD
Capecitabine—Malaise—Ezetimibe—atherosclerosis	0.000565	0.00143	CcSEcCtD
Capecitabine—Vision blurred—Simvastatin—atherosclerosis	0.000563	0.00143	CcSEcCtD
Capecitabine—Arrhythmia—Niacin—atherosclerosis	0.000563	0.00143	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00056	0.00142	CcSEcCtD
Capecitabine—Tremor—Simvastatin—atherosclerosis	0.000559	0.00142	CcSEcCtD
Capecitabine—Alopecia—Niacin—atherosclerosis	0.000557	0.00141	CcSEcCtD
Capecitabine—Chills—Pravastatin—atherosclerosis	0.000556	0.00141	CcSEcCtD
Capecitabine—Insomnia—Rosuvastatin—atherosclerosis	0.000556	0.00141	CcSEcCtD
Capecitabine—Ill-defined disorder—Simvastatin—atherosclerosis	0.000554	0.0014	CcSEcCtD
Capecitabine—Arrhythmia—Pravastatin—atherosclerosis	0.000554	0.0014	CcSEcCtD
Capecitabine—Palpitations—Ezetimibe—atherosclerosis	0.000553	0.0014	CcSEcCtD
Capecitabine—Paraesthesia—Rosuvastatin—atherosclerosis	0.000552	0.0014	CcSEcCtD
Capecitabine—Anaemia—Simvastatin—atherosclerosis	0.000552	0.0014	CcSEcCtD
Capecitabine—Erythema—Niacin—atherosclerosis	0.000548	0.00139	CcSEcCtD
Capecitabine—Malnutrition—Niacin—atherosclerosis	0.000548	0.00139	CcSEcCtD
Capecitabine—Alopecia—Pravastatin—atherosclerosis	0.000548	0.00139	CcSEcCtD
Capecitabine—Cough—Ezetimibe—atherosclerosis	0.000546	0.00138	CcSEcCtD
Capecitabine—Chest pain—Lovastatin—atherosclerosis	0.000543	0.00138	CcSEcCtD
Capecitabine—Arthralgia—Lovastatin—atherosclerosis	0.000543	0.00138	CcSEcCtD
Capecitabine—Myalgia—Lovastatin—atherosclerosis	0.000543	0.00138	CcSEcCtD
Capecitabine—Anxiety—Lovastatin—atherosclerosis	0.000542	0.00137	CcSEcCtD
Capecitabine—Dyspepsia—Rosuvastatin—atherosclerosis	0.000541	0.00137	CcSEcCtD
Capecitabine—Hypertension—Ezetimibe—atherosclerosis	0.000541	0.00137	CcSEcCtD
Capecitabine—Flatulence—Niacin—atherosclerosis	0.00054	0.00137	CcSEcCtD
Capecitabine—Malaise—Simvastatin—atherosclerosis	0.000538	0.00136	CcSEcCtD
Capecitabine—Discomfort—Lovastatin—atherosclerosis	0.000537	0.00136	CcSEcCtD
Capecitabine—Vertigo—Simvastatin—atherosclerosis	0.000536	0.00136	CcSEcCtD
Capecitabine—Leukopenia—Simvastatin—atherosclerosis	0.000534	0.00135	CcSEcCtD
Capecitabine—Chest pain—Ezetimibe—atherosclerosis	0.000533	0.00135	CcSEcCtD
Capecitabine—Myalgia—Ezetimibe—atherosclerosis	0.000533	0.00135	CcSEcCtD
Capecitabine—Arthralgia—Ezetimibe—atherosclerosis	0.000533	0.00135	CcSEcCtD
Capecitabine—Flatulence—Pravastatin—atherosclerosis	0.000532	0.00135	CcSEcCtD
Capecitabine—Dry mouth—Lovastatin—atherosclerosis	0.000532	0.00135	CcSEcCtD
Capecitabine—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000529	0.00134	CcSEcCtD
Capecitabine—Dysgeusia—Pravastatin—atherosclerosis	0.000529	0.00134	CcSEcCtD
Capecitabine—Muscle spasms—Niacin—atherosclerosis	0.000527	0.00134	CcSEcCtD
Capecitabine—Discomfort—Ezetimibe—atherosclerosis	0.000527	0.00133	CcSEcCtD
Capecitabine—Pain—Rosuvastatin—atherosclerosis	0.000526	0.00133	CcSEcCtD
Capecitabine—Constipation—Rosuvastatin—atherosclerosis	0.000526	0.00133	CcSEcCtD
Capecitabine—Confusional state—Lovastatin—atherosclerosis	0.000525	0.00133	CcSEcCtD
Capecitabine—Dry mouth—Ezetimibe—atherosclerosis	0.000521	0.00132	CcSEcCtD
Capecitabine—Muscle spasms—Pravastatin—atherosclerosis	0.000519	0.00132	CcSEcCtD
Capecitabine—Infection—Lovastatin—atherosclerosis	0.000518	0.00131	CcSEcCtD
Capecitabine—Vision blurred—Niacin—atherosclerosis	0.000517	0.00131	CcSEcCtD
Capecitabine—Confusional state—Ezetimibe—atherosclerosis	0.000515	0.00131	CcSEcCtD
Capecitabine—Thrombocytopenia—Lovastatin—atherosclerosis	0.00051	0.00129	CcSEcCtD
Capecitabine—Vision blurred—Pravastatin—atherosclerosis	0.000509	0.00129	CcSEcCtD
Capecitabine—Arthralgia—Simvastatin—atherosclerosis	0.000508	0.00129	CcSEcCtD
Capecitabine—Chest pain—Simvastatin—atherosclerosis	0.000508	0.00129	CcSEcCtD
Capecitabine—Myalgia—Simvastatin—atherosclerosis	0.000508	0.00129	CcSEcCtD
Capecitabine—Infection—Ezetimibe—atherosclerosis	0.000508	0.00129	CcSEcCtD
Capecitabine—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000507	0.00128	CcSEcCtD
Capecitabine—Anxiety—Simvastatin—atherosclerosis	0.000507	0.00128	CcSEcCtD
Capecitabine—Tremor—Pravastatin—atherosclerosis	0.000506	0.00128	CcSEcCtD
Capecitabine—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000503	0.00127	CcSEcCtD
Capecitabine—Discomfort—Simvastatin—atherosclerosis	0.000502	0.00127	CcSEcCtD
Capecitabine—Nervous system disorder—Ezetimibe—atherosclerosis	0.000501	0.00127	CcSEcCtD
Capecitabine—Ill-defined disorder—Pravastatin—atherosclerosis	0.000501	0.00127	CcSEcCtD
Capecitabine—Thrombocytopenia—Ezetimibe—atherosclerosis	0.0005	0.00127	CcSEcCtD
Capecitabine—Anaemia—Pravastatin—atherosclerosis	0.000499	0.00126	CcSEcCtD
Capecitabine—Anorexia—Lovastatin—atherosclerosis	0.000497	0.00126	CcSEcCtD
Capecitabine—Skin disorder—Ezetimibe—atherosclerosis	0.000496	0.00126	CcSEcCtD
Capecitabine—Vertigo—Niacin—atherosclerosis	0.000493	0.00125	CcSEcCtD
Capecitabine—Syncope—Niacin—atherosclerosis	0.000492	0.00125	CcSEcCtD
Capecitabine—Confusional state—Simvastatin—atherosclerosis	0.000491	0.00125	CcSEcCtD
Capecitabine—Leukopenia—Niacin—atherosclerosis	0.000491	0.00124	CcSEcCtD
Capecitabine—Urticaria—Rosuvastatin—atherosclerosis	0.000488	0.00124	CcSEcCtD
Capecitabine—Oedema—Simvastatin—atherosclerosis	0.000487	0.00123	CcSEcCtD
Capecitabine—Malaise—Pravastatin—atherosclerosis	0.000487	0.00123	CcSEcCtD
Capecitabine—Abdominal pain—Rosuvastatin—atherosclerosis	0.000486	0.00123	CcSEcCtD
Capecitabine—Vertigo—Pravastatin—atherosclerosis	0.000485	0.00123	CcSEcCtD
Capecitabine—Palpitations—Niacin—atherosclerosis	0.000485	0.00123	CcSEcCtD
Capecitabine—Infection—Simvastatin—atherosclerosis	0.000484	0.00123	CcSEcCtD
Capecitabine—Leukopenia—Pravastatin—atherosclerosis	0.000483	0.00122	CcSEcCtD
Capecitabine—Loss of consciousness—Niacin—atherosclerosis	0.000482	0.00122	CcSEcCtD
Capecitabine—Cough—Niacin—atherosclerosis	0.000478	0.00121	CcSEcCtD
Capecitabine—Thrombocytopenia—Simvastatin—atherosclerosis	0.000477	0.00121	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000475	0.0012	CcSEcCtD
Capecitabine—Insomnia—Lovastatin—atherosclerosis	0.000471	0.00119	CcSEcCtD
Capecitabine—Cough—Pravastatin—atherosclerosis	0.000471	0.00119	CcSEcCtD
Capecitabine—Paraesthesia—Lovastatin—atherosclerosis	0.000468	0.00119	CcSEcCtD
Capecitabine—Myalgia—Niacin—atherosclerosis	0.000467	0.00118	CcSEcCtD
Capecitabine—Arthralgia—Niacin—atherosclerosis	0.000467	0.00118	CcSEcCtD
Capecitabine—Hypertension—Pravastatin—atherosclerosis	0.000466	0.00118	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000466	0.00118	CcSEcCtD
Capecitabine—Anorexia—Simvastatin—atherosclerosis	0.000465	0.00118	CcSEcCtD
Capecitabine—Dyspnoea—Lovastatin—atherosclerosis	0.000464	0.00118	CcSEcCtD
Capecitabine—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000464	0.00117	CcSEcCtD
Capecitabine—Insomnia—Ezetimibe—atherosclerosis	0.000462	0.00117	CcSEcCtD
Capecitabine—Chest pain—Pravastatin—atherosclerosis	0.00046	0.00116	CcSEcCtD
Capecitabine—Myalgia—Pravastatin—atherosclerosis	0.00046	0.00116	CcSEcCtD
Capecitabine—Arthralgia—Pravastatin—atherosclerosis	0.00046	0.00116	CcSEcCtD
Capecitabine—Paraesthesia—Ezetimibe—atherosclerosis	0.000459	0.00116	CcSEcCtD
Capecitabine—Dyspepsia—Lovastatin—atherosclerosis	0.000459	0.00116	CcSEcCtD
Capecitabine—Anxiety—Pravastatin—atherosclerosis	0.000458	0.00116	CcSEcCtD
Capecitabine—Dry mouth—Niacin—atherosclerosis	0.000456	0.00116	CcSEcCtD
Capecitabine—Dyspnoea—Ezetimibe—atherosclerosis	0.000456	0.00115	CcSEcCtD
Capecitabine—Discomfort—Pravastatin—atherosclerosis	0.000454	0.00115	CcSEcCtD
Capecitabine—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000453	0.00115	CcSEcCtD
Capecitabine—Decreased appetite—Lovastatin—atherosclerosis	0.000453	0.00115	CcSEcCtD
Capecitabine—Dyspepsia—Ezetimibe—atherosclerosis	0.00045	0.00114	CcSEcCtD
Capecitabine—Fatigue—Lovastatin—atherosclerosis	0.000449	0.00114	CcSEcCtD
Capecitabine—Oedema—Niacin—atherosclerosis	0.000447	0.00113	CcSEcCtD
Capecitabine—Constipation—Lovastatin—atherosclerosis	0.000446	0.00113	CcSEcCtD
Capecitabine—Pain—Lovastatin—atherosclerosis	0.000446	0.00113	CcSEcCtD
Capecitabine—Confusional state—Pravastatin—atherosclerosis	0.000444	0.00113	CcSEcCtD
Capecitabine—Decreased appetite—Ezetimibe—atherosclerosis	0.000444	0.00113	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000444	0.00113	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000441	0.00112	CcSEcCtD
Capecitabine—Asthenia—Rosuvastatin—atherosclerosis	0.000441	0.00112	CcSEcCtD
Capecitabine—Insomnia—Simvastatin—atherosclerosis	0.000441	0.00112	CcSEcCtD
Capecitabine—Oedema—Pravastatin—atherosclerosis	0.000441	0.00112	CcSEcCtD
Capecitabine—Fatigue—Ezetimibe—atherosclerosis	0.000441	0.00112	CcSEcCtD
Capecitabine—Shock—Niacin—atherosclerosis	0.00044	0.00112	CcSEcCtD
Capecitabine—Infection—Pravastatin—atherosclerosis	0.000438	0.00111	CcSEcCtD
Capecitabine—Paraesthesia—Simvastatin—atherosclerosis	0.000438	0.00111	CcSEcCtD
Capecitabine—Pain—Ezetimibe—atherosclerosis	0.000437	0.00111	CcSEcCtD
Capecitabine—Constipation—Ezetimibe—atherosclerosis	0.000437	0.00111	CcSEcCtD
Capecitabine—Tachycardia—Niacin—atherosclerosis	0.000437	0.00111	CcSEcCtD
Capecitabine—Pruritus—Rosuvastatin—atherosclerosis	0.000435	0.0011	CcSEcCtD
Capecitabine—Skin disorder—Niacin—atherosclerosis	0.000435	0.0011	CcSEcCtD
Capecitabine—Dyspnoea—Simvastatin—atherosclerosis	0.000434	0.0011	CcSEcCtD
Capecitabine—Hyperhidrosis—Niacin—atherosclerosis	0.000433	0.0011	CcSEcCtD
Capecitabine—Thrombocytopenia—Pravastatin—atherosclerosis	0.000431	0.00109	CcSEcCtD
Capecitabine—Feeling abnormal—Lovastatin—atherosclerosis	0.000429	0.00109	CcSEcCtD
Capecitabine—Dyspepsia—Simvastatin—atherosclerosis	0.000429	0.00109	CcSEcCtD
Capecitabine—Anorexia—Niacin—atherosclerosis	0.000427	0.00108	CcSEcCtD
Capecitabine—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000426	0.00108	CcSEcCtD
Capecitabine—Hyperhidrosis—Pravastatin—atherosclerosis	0.000426	0.00108	CcSEcCtD
Capecitabine—Decreased appetite—Simvastatin—atherosclerosis	0.000424	0.00107	CcSEcCtD
Capecitabine—Feeling abnormal—Ezetimibe—atherosclerosis	0.000421	0.00107	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000421	0.00107	CcSEcCtD
Capecitabine—Diarrhoea—Rosuvastatin—atherosclerosis	0.000421	0.00107	CcSEcCtD
Capecitabine—Fatigue—Simvastatin—atherosclerosis	0.00042	0.00106	CcSEcCtD
Capecitabine—Anorexia—Pravastatin—atherosclerosis	0.00042	0.00106	CcSEcCtD
Capecitabine—Hypotension—Niacin—atherosclerosis	0.000418	0.00106	CcSEcCtD
Capecitabine—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000418	0.00106	CcSEcCtD
Capecitabine—Pain—Simvastatin—atherosclerosis	0.000417	0.00106	CcSEcCtD
Capecitabine—Constipation—Simvastatin—atherosclerosis	0.000417	0.00106	CcSEcCtD
Capecitabine—Urticaria—Lovastatin—atherosclerosis	0.000414	0.00105	CcSEcCtD
Capecitabine—Abdominal pain—Lovastatin—atherosclerosis	0.000412	0.00104	CcSEcCtD
Capecitabine—Body temperature increased—Lovastatin—atherosclerosis	0.000412	0.00104	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000408	0.00103	CcSEcCtD
Capecitabine—Dizziness—Rosuvastatin—atherosclerosis	0.000407	0.00103	CcSEcCtD
Capecitabine—Urticaria—Ezetimibe—atherosclerosis	0.000406	0.00103	CcSEcCtD
Capecitabine—Insomnia—Niacin—atherosclerosis	0.000405	0.00103	CcSEcCtD
Capecitabine—Abdominal pain—Ezetimibe—atherosclerosis	0.000404	0.00102	CcSEcCtD
Capecitabine—Body temperature increased—Ezetimibe—atherosclerosis	0.000404	0.00102	CcSEcCtD
Capecitabine—Paraesthesia—Niacin—atherosclerosis	0.000402	0.00102	CcSEcCtD
Capecitabine—Feeling abnormal—Simvastatin—atherosclerosis	0.000402	0.00102	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000401	0.00102	CcSEcCtD
Capecitabine—Dyspnoea—Niacin—atherosclerosis	0.000399	0.00101	CcSEcCtD
Capecitabine—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000398	0.00101	CcSEcCtD
Capecitabine—Insomnia—Pravastatin—atherosclerosis	0.000398	0.00101	CcSEcCtD
Capecitabine—Paraesthesia—Pravastatin—atherosclerosis	0.000396	0.001	CcSEcCtD
Capecitabine—Dyspepsia—Niacin—atherosclerosis	0.000394	0.000998	CcSEcCtD
Capecitabine—Dyspnoea—Pravastatin—atherosclerosis	0.000393	0.000995	CcSEcCtD
Capecitabine—Decreased appetite—Niacin—atherosclerosis	0.000389	0.000986	CcSEcCtD
Capecitabine—Dyspepsia—Pravastatin—atherosclerosis	0.000388	0.000983	CcSEcCtD
Capecitabine—Rash—Rosuvastatin—atherosclerosis	0.000388	0.000982	CcSEcCtD
Capecitabine—Dermatitis—Rosuvastatin—atherosclerosis	0.000387	0.000981	CcSEcCtD
Capecitabine—Urticaria—Simvastatin—atherosclerosis	0.000387	0.000981	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Niacin—atherosclerosis	0.000386	0.000979	CcSEcCtD
Capecitabine—Abdominal pain—Simvastatin—atherosclerosis	0.000385	0.000976	CcSEcCtD
Capecitabine—Body temperature increased—Simvastatin—atherosclerosis	0.000385	0.000976	CcSEcCtD
Capecitabine—Headache—Rosuvastatin—atherosclerosis	0.000385	0.000976	CcSEcCtD
Capecitabine—Hypersensitivity—Lovastatin—atherosclerosis	0.000384	0.000973	CcSEcCtD
Capecitabine—Decreased appetite—Pravastatin—atherosclerosis	0.000383	0.000971	CcSEcCtD
Capecitabine—Pain—Niacin—atherosclerosis	0.000383	0.00097	CcSEcCtD
Capecitabine—Fatigue—Pravastatin—atherosclerosis	0.00038	0.000963	CcSEcCtD
Capecitabine—Pain—Pravastatin—atherosclerosis	0.000377	0.000955	CcSEcCtD
Capecitabine—Constipation—Pravastatin—atherosclerosis	0.000377	0.000955	CcSEcCtD
Capecitabine—Hypersensitivity—Ezetimibe—atherosclerosis	0.000376	0.000954	CcSEcCtD
Capecitabine—Asthenia—Lovastatin—atherosclerosis	0.000374	0.000947	CcSEcCtD
Capecitabine—Pruritus—Lovastatin—atherosclerosis	0.000369	0.000934	CcSEcCtD
Capecitabine—Asthenia—Ezetimibe—atherosclerosis	0.000367	0.000929	CcSEcCtD
Capecitabine—Gastrointestinal pain—Niacin—atherosclerosis	0.000366	0.000927	CcSEcCtD
Capecitabine—Nausea—Rosuvastatin—atherosclerosis	0.000365	0.000925	CcSEcCtD
Capecitabine—Feeling abnormal—Pravastatin—atherosclerosis	0.000363	0.00092	CcSEcCtD
Capecitabine—Pruritus—Ezetimibe—atherosclerosis	0.000362	0.000916	CcSEcCtD
Capecitabine—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00036	0.000913	CcSEcCtD
Capecitabine—Hypersensitivity—Simvastatin—atherosclerosis	0.000359	0.00091	CcSEcCtD
Capecitabine—Diarrhoea—Lovastatin—atherosclerosis	0.000356	0.000903	CcSEcCtD
Capecitabine—Urticaria—Niacin—atherosclerosis	0.000355	0.000901	CcSEcCtD
Capecitabine—Abdominal pain—Niacin—atherosclerosis	0.000354	0.000896	CcSEcCtD
Capecitabine—Body temperature increased—Niacin—atherosclerosis	0.000354	0.000896	CcSEcCtD
Capecitabine—Urticaria—Pravastatin—atherosclerosis	0.00035	0.000887	CcSEcCtD
Capecitabine—Asthenia—Simvastatin—atherosclerosis	0.00035	0.000886	CcSEcCtD
Capecitabine—Diarrhoea—Ezetimibe—atherosclerosis	0.00035	0.000886	CcSEcCtD
Capecitabine—Abdominal pain—Pravastatin—atherosclerosis	0.000348	0.000883	CcSEcCtD
Capecitabine—Body temperature increased—Pravastatin—atherosclerosis	0.000348	0.000883	CcSEcCtD
Capecitabine—Pruritus—Simvastatin—atherosclerosis	0.000345	0.000874	CcSEcCtD
Capecitabine—Dizziness—Lovastatin—atherosclerosis	0.000345	0.000873	CcSEcCtD
Capecitabine—Dizziness—Ezetimibe—atherosclerosis	0.000338	0.000856	CcSEcCtD
Capecitabine—Diarrhoea—Simvastatin—atherosclerosis	0.000333	0.000845	CcSEcCtD
Capecitabine—Vomiting—Lovastatin—atherosclerosis	0.000331	0.000839	CcSEcCtD
Capecitabine—Hypersensitivity—Niacin—atherosclerosis	0.00033	0.000835	CcSEcCtD
Capecitabine—Rash—Lovastatin—atherosclerosis	0.000328	0.000832	CcSEcCtD
Capecitabine—Dermatitis—Lovastatin—atherosclerosis	0.000328	0.000832	CcSEcCtD
Capecitabine—Headache—Lovastatin—atherosclerosis	0.000326	0.000827	CcSEcCtD
Capecitabine—Vomiting—Ezetimibe—atherosclerosis	0.000325	0.000823	CcSEcCtD
Capecitabine—Hypersensitivity—Pravastatin—atherosclerosis	0.000325	0.000823	CcSEcCtD
Capecitabine—Dizziness—Simvastatin—atherosclerosis	0.000322	0.000817	CcSEcCtD
Capecitabine—Rash—Ezetimibe—atherosclerosis	0.000322	0.000817	CcSEcCtD
Capecitabine—Dermatitis—Ezetimibe—atherosclerosis	0.000322	0.000816	CcSEcCtD
Capecitabine—Asthenia—Niacin—atherosclerosis	0.000321	0.000814	CcSEcCtD
Capecitabine—Headache—Ezetimibe—atherosclerosis	0.00032	0.000811	CcSEcCtD
Capecitabine—Pruritus—Niacin—atherosclerosis	0.000317	0.000802	CcSEcCtD
Capecitabine—Asthenia—Pravastatin—atherosclerosis	0.000316	0.000801	CcSEcCtD
Capecitabine—Pruritus—Pravastatin—atherosclerosis	0.000312	0.00079	CcSEcCtD
Capecitabine—Vomiting—Simvastatin—atherosclerosis	0.00031	0.000785	CcSEcCtD
Capecitabine—Nausea—Lovastatin—atherosclerosis	0.000309	0.000784	CcSEcCtD
Capecitabine—Rash—Simvastatin—atherosclerosis	0.000307	0.000779	CcSEcCtD
Capecitabine—Dermatitis—Simvastatin—atherosclerosis	0.000307	0.000778	CcSEcCtD
Capecitabine—Diarrhoea—Niacin—atherosclerosis	0.000306	0.000776	CcSEcCtD
Capecitabine—Headache—Simvastatin—atherosclerosis	0.000305	0.000774	CcSEcCtD
Capecitabine—Nausea—Ezetimibe—atherosclerosis	0.000304	0.000769	CcSEcCtD
Capecitabine—Diarrhoea—Pravastatin—atherosclerosis	0.000301	0.000764	CcSEcCtD
Capecitabine—Dizziness—Niacin—atherosclerosis	0.000296	0.00075	CcSEcCtD
Capecitabine—Dizziness—Pravastatin—atherosclerosis	0.000291	0.000738	CcSEcCtD
Capecitabine—Nausea—Simvastatin—atherosclerosis	0.000289	0.000734	CcSEcCtD
Capecitabine—Vomiting—Niacin—atherosclerosis	0.000284	0.000721	CcSEcCtD
Capecitabine—Rash—Niacin—atherosclerosis	0.000282	0.000715	CcSEcCtD
Capecitabine—Dermatitis—Niacin—atherosclerosis	0.000282	0.000714	CcSEcCtD
Capecitabine—Headache—Niacin—atherosclerosis	0.00028	0.00071	CcSEcCtD
Capecitabine—Vomiting—Pravastatin—atherosclerosis	0.00028	0.00071	CcSEcCtD
Capecitabine—Rash—Pravastatin—atherosclerosis	0.000278	0.000704	CcSEcCtD
Capecitabine—Dermatitis—Pravastatin—atherosclerosis	0.000278	0.000703	CcSEcCtD
Capecitabine—Headache—Pravastatin—atherosclerosis	0.000276	0.000699	CcSEcCtD
Capecitabine—Nausea—Niacin—atherosclerosis	0.000266	0.000674	CcSEcCtD
Capecitabine—Nausea—Pravastatin—atherosclerosis	0.000262	0.000663	CcSEcCtD
Capecitabine—DPYD—Metabolism—APOC3—atherosclerosis	0.000257	0.00123	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—CYP27A1—atherosclerosis	0.000257	0.00123	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—LDLR—atherosclerosis	0.000256	0.00122	CbGpPWpGaD
Capecitabine—CYP2C9—Arachidonic acid metabolism—GPX1—atherosclerosis	0.000254	0.00122	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—CETP—atherosclerosis	0.00025	0.00119	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—LEP—atherosclerosis	0.000249	0.00119	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—ESR1—atherosclerosis	0.000248	0.00118	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—ALOX5AP—atherosclerosis	0.000243	0.00116	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PLA2G2A—atherosclerosis	0.000243	0.00116	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—APOA2—atherosclerosis	0.000243	0.00116	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—ALOX15—atherosclerosis	0.000243	0.00116	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—LDLRAP1—atherosclerosis	0.000243	0.00116	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—ABCG5—atherosclerosis	0.00024	0.00115	CbGpPWpGaD
Capecitabine—CYP2C9—Biological oxidations—CYP7A1—atherosclerosis	0.00024	0.00115	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—SCARB1—atherosclerosis	0.000239	0.00114	CbGpPWpGaD
Capecitabine—CYP2C9—Metapathway biotransformation—CYP7A1—atherosclerosis	0.000236	0.00113	CbGpPWpGaD
Capecitabine—CDA—Metabolism—NAMPT—atherosclerosis	0.000232	0.00111	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—LPA—atherosclerosis	0.000232	0.00111	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—NOS2—atherosclerosis	0.000232	0.00111	CbGpPWpGaD
Capecitabine—CDA—Metabolism—LIPC—atherosclerosis	0.000231	0.0011	CbGpPWpGaD
Capecitabine—CES1—NRF2 pathway—TGFB1—atherosclerosis	0.00023	0.0011	CbGpPWpGaD
Capecitabine—CDA—Metabolism—APOC3—atherosclerosis	0.000229	0.0011	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PLTP—atherosclerosis	0.000229	0.00109	CbGpPWpGaD
Capecitabine—CDA—Metabolism—LDLR—atherosclerosis	0.000228	0.00109	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—HMGCR—atherosclerosis	0.000226	0.00108	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—BGN—atherosclerosis	0.000225	0.00108	CbGpPWpGaD
Capecitabine—CDA—Metabolism—CETP—atherosclerosis	0.000223	0.00106	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—APOA5—atherosclerosis	0.000223	0.00106	CbGpPWpGaD
Capecitabine—CYP2C9—Biological oxidations—CYP27A1—atherosclerosis	0.000221	0.00106	CbGpPWpGaD
Capecitabine—CYP2C9—Metapathway biotransformation—CYP27A1—atherosclerosis	0.000218	0.00104	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—PPARG—atherosclerosis	0.000217	0.00104	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—IGF1—atherosclerosis	0.000214	0.00103	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PLA2G1B—atherosclerosis	0.000214	0.00102	CbGpPWpGaD
Capecitabine—CDA—Metabolism—SCARB1—atherosclerosis	0.000213	0.00102	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—ALOX5—atherosclerosis	0.000207	0.000989	CbGpPWpGaD
Capecitabine—CDA—Metabolism—HMGCR—atherosclerosis	0.000201	0.000962	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—ABCA1—atherosclerosis	0.000201	0.000962	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—ABCG8—atherosclerosis	0.000198	0.000948	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—LTA4H—atherosclerosis	0.000198	0.000948	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—SERPINE1—atherosclerosis	0.000196	0.000935	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—NAMPT—atherosclerosis	0.000186	0.000887	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—LIPC—atherosclerosis	0.000184	0.000882	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—APOC3—atherosclerosis	0.000183	0.000876	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—LDLR—atherosclerosis	0.000182	0.000871	CbGpPWpGaD
Capecitabine—CDA—Metabolism—ABCA1—atherosclerosis	0.000179	0.000858	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—CETP—atherosclerosis	0.000178	0.000851	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—atherosclerosis	0.000178	0.00085	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—HMOX1—atherosclerosis	0.000173	0.000826	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—SCARB1—atherosclerosis	0.00017	0.000815	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—APOB—atherosclerosis	0.000165	0.000791	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—HMGCR—atherosclerosis	0.000161	0.000769	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—GSTM1—atherosclerosis	0.000161	0.000769	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—LPL—atherosclerosis	0.000158	0.000755	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—LDLRAP1—atherosclerosis	0.000157	0.000753	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—ABCG1—atherosclerosis	0.000157	0.000749	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	0.000154	0.000738	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—GPX1—atherosclerosis	0.000154	0.000737	CbGpPWpGaD
Capecitabine—CDA—Metabolism—HMOX1—atherosclerosis	0.000154	0.000736	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	0.000152	0.000725	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—CD36—atherosclerosis	0.00015	0.000718	CbGpPWpGaD
Capecitabine—CYP2C9—Arachidonic acid metabolism—PTGS2—atherosclerosis	0.00015	0.000716	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PLTP—atherosclerosis	0.000148	0.000708	CbGpPWpGaD
Capecitabine—CDA—Metabolism—APOB—atherosclerosis	0.000147	0.000705	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—FABP4—atherosclerosis	0.000147	0.000705	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—LCAT—atherosclerosis	0.000147	0.000705	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—MAPK8—atherosclerosis	0.000146	0.000696	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—APOA4—atherosclerosis	0.000145	0.000692	CbGpPWpGaD
Capecitabine—CDA—Metabolism—GSTM1—atherosclerosis	0.000143	0.000686	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—ABCA1—atherosclerosis	0.000143	0.000686	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—MTHFR—atherosclerosis	0.000142	0.00068	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—CYP7A1—atherosclerosis	0.000142	0.000679	CbGpPWpGaD
Capecitabine—CDA—Metabolism—LPL—atherosclerosis	0.000141	0.000673	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	0.00014	0.00067	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PPARA—atherosclerosis	0.00014	0.000667	CbGpPWpGaD
Capecitabine—CDA—Metabolism—GPX1—atherosclerosis	0.000137	0.000657	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—AGT—atherosclerosis	0.000135	0.000646	CbGpPWpGaD
Capecitabine—CDA—Metabolism—CD36—atherosclerosis	0.000134	0.00064	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	0.000133	0.000634	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—APOE—atherosclerosis	0.000132	0.000633	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—CYP27A1—atherosclerosis	0.000131	0.000628	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—CAV1—atherosclerosis	0.000131	0.000627	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—APOA1—atherosclerosis	0.000131	0.000626	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	0.000129	0.000615	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—ABCG8—atherosclerosis	0.000128	0.000614	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—LTA4H—atherosclerosis	0.000128	0.000614	CbGpPWpGaD
Capecitabine—CDA—Metabolism—MTHFR—atherosclerosis	0.000127	0.000606	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PLA2G2A—atherosclerosis	0.000125	0.000595	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—APOA2—atherosclerosis	0.000125	0.000595	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—ALOX15—atherosclerosis	0.000125	0.000595	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—ALOX5AP—atherosclerosis	0.000125	0.000595	CbGpPWpGaD
Capecitabine—CDA—Metabolism—PPARA—atherosclerosis	0.000124	0.000595	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—HMOX1—atherosclerosis	0.000123	0.000588	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—ABCG5—atherosclerosis	0.000123	0.000588	CbGpPWpGaD
Capecitabine—CDA—Metabolism—AGT—atherosclerosis	0.00012	0.000576	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	0.00012	0.000574	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PIK3CG—atherosclerosis	0.00012	0.000571	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—LPA—atherosclerosis	0.000119	0.000568	CbGpPWpGaD
Capecitabine—CDA—Metabolism—APOE—atherosclerosis	0.000118	0.000564	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—APOB—atherosclerosis	0.000118	0.000564	CbGpPWpGaD
Capecitabine—CDA—Metabolism—CAV1—atherosclerosis	0.000117	0.000559	CbGpPWpGaD
Capecitabine—CDA—Metabolism—APOA1—atherosclerosis	0.000117	0.000558	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PPARG—atherosclerosis	0.000115	0.000551	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—BGN—atherosclerosis	0.000115	0.00055	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—GSTM1—atherosclerosis	0.000115	0.000548	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—APOA5—atherosclerosis	0.000114	0.000544	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—INS—atherosclerosis	0.000113	0.000541	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—LPL—atherosclerosis	0.000113	0.000538	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—GPX1—atherosclerosis	0.00011	0.000525	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PLA2G1B—atherosclerosis	0.00011	0.000524	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—CD36—atherosclerosis	0.000107	0.000511	CbGpPWpGaD
Capecitabine—CDA—Metabolism—PIK3CG—atherosclerosis	0.000107	0.000509	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—ALOX5—atherosclerosis	0.000106	0.000506	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—ALB—atherosclerosis	0.000104	0.000496	CbGpPWpGaD
Capecitabine—CDA—Metabolism—PPARG—atherosclerosis	0.000103	0.000491	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—ABCG1—atherosclerosis	0.000101	0.000485	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—MTHFR—atherosclerosis	0.000101	0.000485	CbGpPWpGaD
Capecitabine—CDA—Metabolism—INS—atherosclerosis	0.000101	0.000482	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PPARA—atherosclerosis	9.94e-05	0.000475	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—NOS3—atherosclerosis	9.92e-05	0.000474	CbGpPWpGaD
Capecitabine—CYP2C9—Biological oxidations—GSTM1—atherosclerosis	9.89e-05	0.000473	CbGpPWpGaD
Capecitabine—CYP2C9—Metapathway biotransformation—GSTM1—atherosclerosis	9.75e-05	0.000466	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—AGT—atherosclerosis	9.63e-05	0.00046	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	9.54e-05	0.000456	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	9.54e-05	0.000456	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—NAMPT—atherosclerosis	9.5e-05	0.000454	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—LIPC—atherosclerosis	9.44e-05	0.000451	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—APOE—atherosclerosis	9.44e-05	0.000451	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—APOC3—atherosclerosis	9.38e-05	0.000448	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	9.36e-05	0.000448	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—CAV1—atherosclerosis	9.35e-05	0.000447	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—APOA1—atherosclerosis	9.33e-05	0.000446	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—LDLR—atherosclerosis	9.32e-05	0.000446	CbGpPWpGaD
Capecitabine—TYMS—Circadian rythm related genes—IL6—atherosclerosis	9.3e-05	0.000445	CbGpPWpGaD
Capecitabine—CDA—Metabolism—ALB—atherosclerosis	9.24e-05	0.000442	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	9.2e-05	0.00044	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—CETP—atherosclerosis	9.1e-05	0.000435	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—PTGS2—atherosclerosis	9.07e-05	0.000434	CbGpPWpGaD
Capecitabine—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	8.94e-05	0.000427	CbGpPWpGaD
Capecitabine—CDA—Metabolism—NOS3—atherosclerosis	8.84e-05	0.000423	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—SCARB1—atherosclerosis	8.72e-05	0.000417	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PIK3CG—atherosclerosis	8.52e-05	0.000407	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	8.5e-05	0.000406	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—HMGCR—atherosclerosis	8.23e-05	0.000394	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PPARG—atherosclerosis	8.22e-05	0.000393	CbGpPWpGaD
Capecitabine—CDA—Metabolism—PTGS2—atherosclerosis	8.09e-05	0.000387	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—INS—atherosclerosis	8.06e-05	0.000385	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	8.06e-05	0.000385	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	8.06e-05	0.000385	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	8.06e-05	0.000385	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	8.06e-05	0.000385	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	7.96e-05	0.000381	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	7.69e-05	0.000368	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—ALB—atherosclerosis	7.39e-05	0.000353	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	7.37e-05	0.000352	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—ABCA1—atherosclerosis	7.34e-05	0.000351	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	7.1e-05	0.000339	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—NOS3—atherosclerosis	7.07e-05	0.000338	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—LDLRAP1—atherosclerosis	7.01e-05	0.000335	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	6.85e-05	0.000328	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PLTP—atherosclerosis	6.59e-05	0.000315	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—PTGS2—atherosclerosis	6.47e-05	0.000309	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle, Mitotic—MAPK3—atherosclerosis	6.42e-05	0.000307	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—HMOX1—atherosclerosis	6.3e-05	0.000301	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	6.11e-05	0.000292	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	6.07e-05	0.00029	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	6.03e-05	0.000288	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—APOB—atherosclerosis	6.03e-05	0.000288	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	5.89e-05	0.000282	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GSTM1—atherosclerosis	5.87e-05	0.00028	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—LPL—atherosclerosis	5.76e-05	0.000275	CbGpPWpGaD
Capecitabine—TYMS—Cell Cycle—MAPK3—atherosclerosis	5.74e-05	0.000274	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—LTA4H—atherosclerosis	5.72e-05	0.000273	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ABCG8—atherosclerosis	5.72e-05	0.000273	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	5.64e-05	0.00027	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—GPX1—atherosclerosis	5.62e-05	0.000269	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—CD36—atherosclerosis	5.47e-05	0.000262	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	5.33e-05	0.000255	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—MTHFR—atherosclerosis	5.18e-05	0.000248	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PPARA—atherosclerosis	5.09e-05	0.000243	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—AGT—atherosclerosis	4.93e-05	0.000236	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—APOE—atherosclerosis	4.83e-05	0.000231	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—CAV1—atherosclerosis	4.78e-05	0.000229	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—APOA1—atherosclerosis	4.77e-05	0.000228	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	4.75e-05	0.000227	CbGpPWpGaD
Capecitabine—DPYD—Metabolism—AKT1—atherosclerosis	4.56e-05	0.000218	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ABCG1—atherosclerosis	4.52e-05	0.000216	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PIK3CG—atherosclerosis	4.36e-05	0.000208	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—LCAT—atherosclerosis	4.25e-05	0.000203	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—FABP4—atherosclerosis	4.25e-05	0.000203	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PPARG—atherosclerosis	4.2e-05	0.000201	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—APOA4—atherosclerosis	4.17e-05	0.000199	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—INS—atherosclerosis	4.12e-05	0.000197	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CYP7A1—atherosclerosis	4.1e-05	0.000196	CbGpPWpGaD
Capecitabine—CDA—Metabolism—AKT1—atherosclerosis	4.06e-05	0.000194	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	3.9e-05	0.000187	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CYP27A1—atherosclerosis	3.79e-05	0.000181	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—ALB—atherosclerosis	3.78e-05	0.000181	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	3.73e-05	0.000178	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	3.64e-05	0.000174	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—NOS3—atherosclerosis	3.62e-05	0.000173	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ALOX15—atherosclerosis	3.59e-05	0.000172	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—APOA2—atherosclerosis	3.59e-05	0.000172	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ALOX5AP—atherosclerosis	3.59e-05	0.000172	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PLA2G2A—atherosclerosis	3.59e-05	0.000172	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ABCG5—atherosclerosis	3.55e-05	0.000169	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	3.54e-05	0.000169	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—LPA—atherosclerosis	3.42e-05	0.000164	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—BGN—atherosclerosis	3.32e-05	0.000159	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—PTGS2—atherosclerosis	3.31e-05	0.000158	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	3.29e-05	0.000157	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—APOA5—atherosclerosis	3.28e-05	0.000157	CbGpPWpGaD
Capecitabine—TYMP—Metabolism—AKT1—atherosclerosis	3.25e-05	0.000155	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	3.19e-05	0.000152	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	3.16e-05	0.000151	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	3.12e-05	0.000149	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	3.1e-05	0.000148	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	3.09e-05	0.000148	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ALOX5—atherosclerosis	3.05e-05	0.000146	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	2.82e-05	0.000135	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—NAMPT—atherosclerosis	2.74e-05	0.000131	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	2.72e-05	0.00013	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—LIPC—atherosclerosis	2.72e-05	0.00013	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—APOC3—atherosclerosis	2.7e-05	0.000129	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—LDLR—atherosclerosis	2.69e-05	0.000128	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CETP—atherosclerosis	2.62e-05	0.000125	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—SCARB1—atherosclerosis	2.51e-05	0.00012	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	2.45e-05	0.000117	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—HMGCR—atherosclerosis	2.37e-05	0.000113	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	2.14e-05	0.000102	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ABCA1—atherosclerosis	2.12e-05	0.000101	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—HMOX1—atherosclerosis	1.81e-05	8.68e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—APOB—atherosclerosis	1.74e-05	8.31e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GSTM1—atherosclerosis	1.69e-05	8.08e-05	CbGpPWpGaD
Capecitabine—TYMS—Metabolism—AKT1—atherosclerosis	1.66e-05	7.95e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—LPL—atherosclerosis	1.66e-05	7.94e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—GPX1—atherosclerosis	1.62e-05	7.74e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CD36—atherosclerosis	1.58e-05	7.54e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—MTHFR—atherosclerosis	1.49e-05	7.14e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PPARA—atherosclerosis	1.47e-05	7.01e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—AGT—atherosclerosis	1.42e-05	6.79e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—APOE—atherosclerosis	1.39e-05	6.65e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—CAV1—atherosclerosis	1.38e-05	6.59e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—APOA1—atherosclerosis	1.38e-05	6.58e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PIK3CG—atherosclerosis	1.26e-05	6e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PPARG—atherosclerosis	1.21e-05	5.79e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—INS—atherosclerosis	1.19e-05	5.68e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—ALB—atherosclerosis	1.09e-05	5.21e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—NOS3—atherosclerosis	1.04e-05	4.98e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—PTGS2—atherosclerosis	9.53e-06	4.56e-05	CbGpPWpGaD
Capecitabine—CYP2C9—Metabolism—AKT1—atherosclerosis	4.79e-06	2.29e-05	CbGpPWpGaD
